10:26 AM EST, 11/22/2024 (MT Newswires) -- Autonomix Medical ( AMIX ) said Friday it has priced an underwritten public offering of about 1.4 million common stock and pre-funded warrant units at $6.54 each for gross proceeds of $9 million.

Underwriters have been granted a 45-day option to buy up to 15% additional shares, the company said.

Net proceeds will be allocated to support its clinical trial, research and development, intellectual property development, and working capital, the company said.

The offering is expected to close Monday, the company added.

Autonomix Medical ( AMIX ) shares plunged more than 52% in recent trading.

Price: 6.45, Change: -7.07, Percent Change: -52.29